{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:35:17Z","timestamp":1790854517111,"version":"4.1.0"},"reference-count":37,"publisher":"American Psychiatric Association Publishing","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP"],"published-print":{"date-parts":[[2003,10,1]]},"DOI":"10.1176\/appi.ajp.160.10.1751","type":"journal-article","created":{"date-parts":[[2003,9,26]],"date-time":"2003-09-26T21:41:55Z","timestamp":1064612515000},"page":"1751-1756","source":"Crossref","is-referenced-by-count":40,"title":["Progression of Subcortical Ischemic Disease From Vascular Depression to Vascular Dementia"],"prefix":"10.1176","volume":"160","author":[{"given":"David C.","family":"Steffens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren D.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Ranga Rama","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"230","reference":[{"key":"R16010CIAHBDJJ","doi-asserted-by":"crossref","unstructured":"Folstein MF, Folstein SE, McHugh PR: \u201cMini-Mental State\u201d: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189\u2013198","DOI":"10.1016\/0022-3956(75)90026-6"},{"key":"R16010CIAGABJF","doi-asserted-by":"crossref","unstructured":"Payne ME, Fetzer DL, MacFall JR, Provenzale JM, Byrum CE, Krishnan KRR: Development of a semi-automated method for quantification of MRI gray and white matter lesions in geriatric subjects. Psychiatry Res 2002; 115:63\u201377","DOI":"10.1016\/S0925-4927(02)00009-4"},{"key":"R16010CIADGAGA","doi-asserted-by":"crossref","unstructured":"Krishnan KRR, McDonald WM: Arteriosclerotic depression. Med Hypotheses 1995; 44:111\u2013115","DOI":"10.1016\/0306-9877(95)90081-0"},{"key":"R16010CIAEHCDA","doi-asserted-by":"crossref","unstructured":"Krishnan KRR, Hays JC, Blazer DG: MRI-defined vascular depression. Am J Psychiatry 1997; 154:497\u2013501","DOI":"10.1176\/ajp.154.4.497"},{"key":"R16010CIAFFAAD","doi-asserted-by":"crossref","unstructured":"Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M: \u201cVascular depression\u201d hypothesis. Arch Gen Psychiatry 1997; 54:915\u2013922","DOI":"10.1001\/archpsyc.1997.01830220033006"},{"key":"R16010CIAFJJCE","doi-asserted-by":"crossref","unstructured":"Krishnan KRR, Goli V, Ellinwood EH, France RD, Blazer DZ, Nemeroff CB: Leukoencephalopathy in patients diagnosed as major depressive. Biol Psychiatry 1988; 1988; 23:519\u2013522","DOI":"10.1016\/0006-3223(88)90025-X"},{"key":"atypb1","doi-asserted-by":"crossref","unstructured":"Greenwald BS, Kramer-Ginsberg E, Krishnan KRR, Ashtari M, Aupperle PM, Patel M: MRI signal hyperintensities in geriatric depression. Am J Psychiatry 1996; 153:1212\u20131215","DOI":"10.1176\/ajp.153.9.1212"},{"key":"R16010CIAGCBCJ","doi-asserted-by":"crossref","unstructured":"Kumar A, Bilker W, Jin Z, Udupa J: Atrophy and high intensity lesions: complementary neurobiological mechanisms in late-life depression. Neuropsychopharmacology 2000; 22:264\u2013274","DOI":"10.1016\/S0893-133X(99)00124-4"},{"key":"R16010CIAJCECA","doi-asserted-by":"crossref","unstructured":"Looi JCL, Sachdev PS: Differentiation of vascular dementia from Alzheimer\u2019s disease on neuropsychological tests. Neurology 1999; 53:670\u2013678","DOI":"10.1212\/WNL.53.4.670"},{"key":"R16010CIAHEEAH","doi-asserted-by":"crossref","unstructured":"Kerber KA, Enrietto JA, Jacobson KM, Baloh RW: Disequilibrium in older people: a prospective study. Neurology 1998; 51:574\u2013580","DOI":"10.1212\/WNL.51.2.574"},{"key":"R16010CIAICCBB","doi-asserted-by":"crossref","unstructured":"Longstreth WT Jr, Manolio TA, Arnold A, Burke GL, Bryan N, Jungreis CA, Enright PL, O\u2019Leary D, Fried L: Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people: the Cardiovascular Health Study. Stroke 1996; 27:1274\u20131282","DOI":"10.1161\/01.STR.27.8.1274"},{"key":"atypb2","doi-asserted-by":"crossref","unstructured":"Fazekas F, Niederkor K, Schmidt R, Offenbacher H, Honner S, Bertha G, Lechner H: White matter signal abnormalities in normal individuals: correlation with carotid ultrasonography, cerebral blood flow measurements, and cerebrovascular risk factors. Stroke 1988; 19:1285\u20131288","DOI":"10.1161\/01.STR.19.10.1285"},{"key":"atypb3","doi-asserted-by":"crossref","unstructured":"Ylikoski A, Erkinjuntti T, Raininko R, Sarna S, Sulkava R, Tilvis R: White matter hyperintensities on MRI in the neurologically nondiseased elderly: analysis of cohorts of consecutive subjects aged 55 to 85 years living at home. Stroke 1995; 26:1171\u20131177","DOI":"10.1161\/01.STR.26.7.1171"},{"key":"R16010CIABAFGD","doi-asserted-by":"crossref","unstructured":"Sato R, Bryan RN, Fried LP: Neuroanatomic and functional correlates of depressed mood: the Cardiovascular Health Study. Am J Epidemiol 1999; 150:919\u2013929","DOI":"10.1093\/oxfordjournals.aje.a010100"},{"key":"R16010CIADJJJA","doi-asserted-by":"crossref","unstructured":"Awad IA, Spetzler RF, Hodak JA, Awad CA, Carey R: Incidental subcortical lesions identified on magnetic resonance imaging in the elderly, I: correlation with age and cerebrovascular risk factors. Stroke 1986; 17:1084\u20131089","DOI":"10.1161\/01.STR.17.6.1084"},{"key":"R16010CIAEEEEH","doi-asserted-by":"crossref","unstructured":"Inzitari D, Diaz F, Fox A, Hachinski VC, Steingart A, Lau C, Donald A, Wade J, Mulic H, Merskey H: Vascular risk factors and leukoariosis. Arch Neurol 1987; 44:42\u201347","DOI":"10.1001\/archneur.1987.00520130034014"},{"key":"R16010CIAHGACA","doi-asserted-by":"crossref","unstructured":"Carmelli D, Reed T, DeCarli C: A bivariate genetic analysis of cerebral white matter hyperintensities and cognitive performance in elderly male twins. Neurobiol Aging 2002; 23:413\u2013420","DOI":"10.1016\/S0197-4580(01)00336-0"},{"key":"R16010CIAFDHAD","doi-asserted-by":"crossref","unstructured":"Fredman SJ, Fava M, Kienke AS, White CN, Nierenberg AA, Rosenbaum JF: Partial response, nonresponse, and relapse with selective serotonin reuptake inhibitors in major depression: a survey of current \u201cnext-step\u201d practices. J Clin Psychiatry 2000; 61:403\u2013408","DOI":"10.4088\/JCP.v61n0602"},{"key":"R16010CIABAEAA","unstructured":"Brown WA, Harrison W: Are patients who are intolerant to one serotonin selective reuptake inhibitor intolerant to another? J Clin Psychiatry 1995; 56:30\u201334"},{"key":"atypb4","unstructured":"Zarate CA, Kando JC, Tohen M, Weiss MK, Cole JO: Does intolerance or lack of response with fluoxetine predict the same will happen with sertraline? J Clin Psychiatry 1996; 57:67\u201371"},{"key":"atypb5","unstructured":"Joffe RT, Levitt AJ, Sokolov ST, Young LT: Response to an open trial of a second SSRI in major depression. J Clin Psychiatry 1996; 58:236\u2013237"},{"key":"R16010CIAJADID","doi-asserted-by":"crossref","unstructured":"Thase ME, Blomgren SL, Birkett MA, Apter JT, Tepner RG: Fluoxetine treatment of patients with major depressive disorder who failed initial treatment with sertraline. J Clin Psychiatry 1997; 58:16\u201321","DOI":"10.4088\/JCP.v58n0103"},{"key":"R16010CIAIDIHA","doi-asserted-by":"crossref","unstructured":"Krishnan KRR, Doraiswamy PM, Clary CM: Clinical and treatment response characteristics of late-life depression associated with vascular disease: a pooled analysis of two multicenter trials with sertraline. Prog Neuropsychopharmacol Biol Psychiatry 2001; 25:347\u2013351","DOI":"10.1016\/S0278-5846(00)00168-8"},{"key":"R16010CIAFDCIF","doi-asserted-by":"crossref","unstructured":"Glassman AH, O\u2019Connor CM, Califf RM, Swedberg K, Schwartz P, Bigger JT, Krishnan KRR, van Zyl LT, Swenson JR, Finkel MS, Landau C, Shapiro PA, Pepine CJ, Mardekian J, Harrison WM: Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002; 288:701\u2013709","DOI":"10.1001\/jama.288.6.701"},{"key":"R16010CIACBFJH","doi-asserted-by":"crossref","unstructured":"Bodkin JA, Lasser RA, Wines JD Jr, Gardner DM, Baldessarini RJ: Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy. J Clin Psychiatry 1997; 58:137\u2013145","DOI":"10.4088\/JCP.v58n0401"},{"key":"atypb6","doi-asserted-by":"crossref","unstructured":"Spier SA: Use of bupropion with SRIs and venlafaxine. Depress Anxiety 1998; 7:73\u201375","DOI":"10.1002\/(SICI)1520-6394(1998)7:2<73::AID-DA4>3.3.CO;2-I"},{"key":"R16010CIAFFHGE","doi-asserted-by":"crossref","unstructured":"Ramasubbu R: Treatment of resistant depression by adding noradrenergic agents to lithium augmentation of SSRIs. Ann Pharmacother 2002; 36:634\u2013640","DOI":"10.1345\/1542-6270(2002)036<0634:TORDBA>2.0.CO;2"},{"key":"R16010CIACBEJD","doi-asserted-by":"crossref","unstructured":"Jiang W, Alexander J, Christopher E, Kuchibhatla M, Gaulden LH, Cuffe MS, Blazing MA, Davenport C, Califf RM, Krishnan RR, O\u2019Connor CM: Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med 2001; 161:1849\u20131856","DOI":"10.1001\/archinte.161.15.1849"},{"key":"R16010CIACAGIE","doi-asserted-by":"crossref","unstructured":"Alexopoulos GS, Meyers BS, Young RC, Mattis S, Kakuma T: The course of geriatric depression with \u201creversible dementia\u201d: a controlled study. Am J Psychiatry 1993; 150:1693\u20131699","DOI":"10.1176\/ajp.150.11.1693"},{"key":"R16010CIAFFIJG","doi-asserted-by":"crossref","unstructured":"Cannata AP, Alberoni M, Franceschi M, Mariana C: Frontal impairment in subcortical ischemic vascular dementia in comparison to Alzheimer\u2019s disease. Dement Geriatr Cogn Disord 2002; 13:101\u2013111","DOI":"10.1159\/000048641"},{"key":"R16010CIAJEGAB","doi-asserted-by":"crossref","unstructured":"Chui H: Dementia due to subcortical ischemic vascular disease. Clin Cornerstone 2001; 3:40\u201351","DOI":"10.1016\/S1098-3597(01)90047-X"},{"key":"R16010CIAEDBDF","doi-asserted-by":"crossref","unstructured":"Li Y, Meyer JS, Haque MA, Chowdhury MH, Hinh P, Quach M: Feasibility of vascular dementia treatment with cholinesterase inhibitors. Int J Geriatr Psychiatry 2002; 17:194\u2013196","DOI":"10.1002\/gps.546"},{"key":"R16010CIAIGJJD","doi-asserted-by":"crossref","unstructured":"Mendez MF, Younesi FL, Perryman KM: Use of donepezil for vascular dementia: preliminary clinical experience. J Neuropsychiatry Clin Neurosci 1999; 11:268\u2013270","DOI":"10.1176\/jnp.11.2.268"},{"key":"R16010CIABHIFE","doi-asserted-by":"crossref","unstructured":"Erkinjuntti T, Kurz A, Gauthier S, Bullock R, Lilienfeld S, Rao C, Damaraju V: Efficacy of galantamine in probable vascular dementia and Alzheimer\u2019s disease combined with cerebrovascular disease: a randomised trial. Lancet 2002; 359:1283\u20131290","DOI":"10.1016\/S0140-6736(02)08267-3"},{"key":"R16010CIAHFJIH","doi-asserted-by":"crossref","unstructured":"Schneider LS: Galantamine for vascular dementia: some answers, some questions. Lancet 2002; 359:1265\u20131266","DOI":"10.1016\/S0140-6736(02)08283-1"},{"key":"R16010CIAGECHD","doi-asserted-by":"crossref","unstructured":"Steffens DC, Helms MJ, Krishnan KRR, Burke GL: Cerebrovascular disease and depression symptoms in the Cardiovascular Health Study. Stroke 1999; 30:2159\u20132166","DOI":"10.1161\/01.STR.30.10.2159"},{"key":"R16010CIACCFAD","doi-asserted-by":"crossref","unstructured":"Steffens DC, Krishnan KRR, Crump C, Burke GL: Cerebrovascular disease and evolution of depressive symptoms in the cardiovascular health study. Stroke 2002; 33:1636\u20131644","DOI":"10.1161\/01.STR.0000018405.59799.D5"}],"container-title":["American Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.160.10.1751","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:18:35Z","timestamp":1721866715000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.160.10.1751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10,1]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2003,10,1]]}},"alternative-id":["10.1176\/appi.ajp.160.10.1751"],"URL":"https:\/\/doi.org\/10.1176\/appi.ajp.160.10.1751","relation":{},"ISSN":["0002-953X","1535-7228"],"issn-type":[{"value":"0002-953X","type":"print"},{"value":"1535-7228","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,10,1]]}}}